Gentaur Molecular Products SPRL
4.8 FTEGentaur Molecular Products reported total assets of €1.24m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026), with 4.8 full-time equivalents.
The score of Gentaur Molecular Products shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +51 % Total assets +19 % Headcount (avg FTE) +78 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gentaur Molecular Products's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
Gentaur Molecular Products's financial analysis
- Solvency37.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gentaur Molecular Products
Gentaur Molecular Products's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0473.327.336
- VAT number
- BE0473327336
- Peppol
- Registered · 0208:0473327336 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 22 Nov 2000
- Registered office
- 1910 Kampenhout
- Size
- Micro · 4.8 FTE
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Gentaur Molecular Products (SPRL) has been based in Kampenhout since 2000, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 12,800 € and equity of 470,617 €; its revenue is not published. With 4.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 37.9%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Gentaur Molecular Products
Companies in the same business, of comparable size and area, outside its group.
- Laerdal Benelux Wholesale of pharmaceutical and medical goods Vilvoorde · balance sheet €1.21m
- Epredia Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.24m
- Silimed Benelux Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €1.51m
- Aboca Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.24m
- AUXI Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.20m
- Nomax Wholesale of pharmaceutical and medical goods Zutendaal · balance sheet €1.85m
- bioMérieux Benelux Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet €18.9m
- TFC Médical Wholesale of pharmaceutical and medical goods Theux · balance sheet €1.24m
Frequently asked questions about Gentaur Molecular Products
What is the revenue of Gentaur Molecular Products?
Gentaur Molecular Products files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gentaur Molecular Products?
In Belgium, the VAT number is the company number prefixed with BE: BE0473327336 for Gentaur Molecular Products, if the company is VAT-registered. Its company number (CBE) is 0473.327.336.
Where is the registered office of Gentaur Molecular Products?
According to the CBE register, the registered office of Gentaur Molecular Products is in 1910 Kampenhout.
What is the equity of Gentaur Molecular Products?
At the close of the 2025 financial year, the equity of Gentaur Molecular Products amounts to 470,617 €, a solvency of 37.9% of total assets.
How many people work at Gentaur Molecular Products?
4.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Gentaur Molecular Products?
The register lists 1 active mandates at Gentaur Molecular Products. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gentaur Molecular Products
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →